Watch CBS News

Vaccines

cbsn-fusion-johnson-and-johnson-asks-the-fda-to-give-its-vaccine-emergency-use-authorization-thumbnail-640726-640x360.jpg

Doctor on COVID-19 variants, J&J's vaccine

A third coronavirus vaccine could be available in the U.S. by the end of the month. Johnson and Johnson has asked the Food and Drug Administration to authorize its vaccine for emergency use. "CBS This Morning" lead national correspondent David Begnaud reports several of the new variants of the virus are spreading, and CBSN's Tanya Rivero spoke with infectious disease specialist Dr. Uzma Syed, director of the Antimicrobial Stewardship Center of Excellence at Good Samaritan Hospital Medical Center in New York.

cbsn-fusion-vaccine-distribution-in-the-us-still-faces-inequity-thumbnail-639928-640x360.jpg

Inequities in U.S. vaccine distribution

The pace of COVID-19 vaccine distribution is steadily rising in the U.S., but there are still concerns about inequities. CBS News' David Begnaud reports on the rollout, and Dr. Julie Morita, executive vice president of the Robert Wood Johnson Foundation and former member of the Biden administration's transition advisory board, joins CBSN's Tanya Rivero to discuss what the nation needs to do to ensure the most vulnerable populations aren't left behind.

cbsn-fusion-cdc-27m-americans-have-received-at-least-one-covid-vaccine-dose-thumbnail-639682-640x360.jpg

CDC: 27M+ Americans have gotten at least 1 COVID shot

More than 27 million Americans are on their way to full inoculation after receiving at least one COVID-19 vaccine dose, according to numbers released by the Centers for Disease Control. Dr. Susannah Hills joins CBSN to discuss the increased efforts to vaccinate the country and how having already had the disease can affect getting vaccinated, as well as a new study that suggest reinfection may not be as rare as once thought.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.